Drugs / EVARREST™ Fibrin Sealant Patch
EVARREST™ Fibrin Sealant Patch
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02040428 | Jan 2014 → Jul 2015 | cardiovascular disorder | Ethicon, Inc. | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EVARREST Fibrin Sealant Patch | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02040428 ↗ |
| Modality | Protein / enzyme biologic | “a coating of two biological components (Human Fibrinogen and Human Thrombin)” NCT02040428 ↗ |